- Home
- NIU vs CADL Comparison
NIU vs CADL Comparison
Compare NIU & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIU | CADL |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.6M | 280.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NIU | CADL |
|---|---|---|
| Price | $3.63 | $5.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 427.3K | ★ 927.1K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $125,000.00 |
| Revenue This Year | $42.51 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $4.25 |
| 52 Week High | $5.67 | $9.13 |
Technical Indicators
Market Signals| Indicator | NIU | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 43.55 |
| Support Level | $3.05 | $4.44 |
| Resistance Level | $3.69 | $5.34 |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 43.67 | 39.52 |
Price Performance
Historical ComparisonAbout NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.